Join
Live feed
·
PRReleasevia Quantisnow
CRISPR Therapeutics AG logo
Vertex Pharmaceuticals Incorporated logo

Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress

ByQuantisnow·Wall Street's wire, on your screen.
CRSP· CRISPR Therapeutics AGVRTX· Vertex Pharmaceuticals Incorporated
Health Care
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress | Quantisnow